"Safety and convenience of a 15-minute infusion of zoledronic acid": not so safe.
Lugassy
Gilles
G
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects; D001859:Bone Neoplasms / Q000150:complications / Q000188:drug therapy*; D004002:Clodronic Acid / Q000008:administration & dosage / Q000009:adverse effects; D004164:Diphosphonates / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy* / Q000209:etiology; D000077557:Ibandronic Acid; D007093:Imidazoles / Q000008:administration & dosage* / Q000009:adverse effects; D007262:Infusions, Intravenous; D000077268:Pamidronate; D013997:Time Factors; D000077211:Zoledronic Acid
D000970:Antineoplastic Agents; D004164:Diphosphonates; D007093:Imidazoles; D004002:Clodronic Acid; D000077211:Zoledronic Acid; D000077268:Pamidronate; D000077557:Ibandronic Acid